255 related articles for article (PubMed ID: 28649001)
21. Single agent carboplatin for pediatric low-grade glioma: A retrospective analysis shows equivalent efficacy to multiagent chemotherapy.
Dodgshun AJ; Maixner WJ; Heath JA; Sullivan MJ; Hansford JR
Int J Cancer; 2016 Jan; 138(2):481-8. PubMed ID: 26235348
[TBL] [Abstract][Full Text] [Related]
22. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of novel combination chemotherapy, consisting of 5-fluorouracil, vincristine, cyclophosphamide and etoposide, in the treatment of low-grade gliomas in children.
Lee MJ; Ra YS; Park JB; Goo HW; Ahn SD; Khang SK; Song JS; Kim YJ; Ghim TT
J Neurooncol; 2006 Dec; 80(3):277-84. PubMed ID: 16807782
[TBL] [Abstract][Full Text] [Related]
24. Impact of chemotherapy on disseminated low-grade glioma in children and adolescents: report from the HIT-LGG 1996 trial.
von Hornstein S; Kortmann RD; Pietsch T; Emser A; Warmuth-Metz M; Soerensen N; Straeter R; Graf N; Thieme B; Gnekow AK
Pediatr Blood Cancer; 2011 Jul; 56(7):1046-54. PubMed ID: 21319282
[TBL] [Abstract][Full Text] [Related]
25. Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trial.
Reck M; von Pawel J; Macha HN; Kaukel E; Deppermann KM; Bonnet R; Ulm K; Hessler S; Gatzemeier U
Lung Cancer; 2006 Jul; 53(1):67-75. PubMed ID: 16713013
[TBL] [Abstract][Full Text] [Related]
26. Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology Group.
Ater JL; Zhou T; Holmes E; Mazewski CM; Booth TN; Freyer DR; Lazarus KH; Packer RJ; Prados M; Sposto R; Vezina G; Wisoff JH; Pollack IF
J Clin Oncol; 2012 Jul; 30(21):2641-7. PubMed ID: 22665535
[TBL] [Abstract][Full Text] [Related]
27. Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma.
Franceschi E; Cavallo G; Scopece L; Paioli A; Pession A; Magrini E; Conforti R; Palmerini E; Bartolini S; Rimondini S; Esposti RD; Crinò L
Br J Cancer; 2004 Sep; 91(6):1038-44. PubMed ID: 15305187
[TBL] [Abstract][Full Text] [Related]
28. Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood.
Packer RJ; Lange B; Ater J; Nicholson HS; Allen J; Walker R; Prados M; Jakacki R; Reaman G; Needles MN
J Clin Oncol; 1993 May; 11(5):850-6. PubMed ID: 8487049
[TBL] [Abstract][Full Text] [Related]
29. Retrospective analysis of combination carboplatin and vinblastine for pediatric low-grade glioma.
Nellan A; Wright E; Campbell K; Davies KD; Donson AM; Amani V; Judd A; Hemenway MS; Raybin J; Foreman NK; Rush S; Dorris K
J Neurooncol; 2020 Jul; 148(3):569-575. PubMed ID: 32506370
[TBL] [Abstract][Full Text] [Related]
30. Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults.
Urban C; Benesch M; Pakisch B; Lackner H; Kerbl R; Schwinger W; Oberbauer R
J Neurooncol; 1998 Aug; 39(1):71-80. PubMed ID: 9760072
[TBL] [Abstract][Full Text] [Related]
31. Outcome of newly diagnosed high risk medulloblastoma treated with carboplatin, vincristine, cyclophosphamide and etoposide.
Sirachainan N; Pakakasama S; Anurathapan U; Hansasuta A; Dhanachai M; Khongkhatithum C; Jinawath A; Mahachoklertwattana P; Hongeng S
J Clin Neurosci; 2018 Oct; 56():139-142. PubMed ID: 29960842
[TBL] [Abstract][Full Text] [Related]
32. Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial.
Ladenstein R; Pötschger U; Valteau-Couanet D; Luksch R; Castel V; Yaniv I; Laureys G; Brock P; Michon JM; Owens C; Trahair T; Chan GCF; Ruud E; Schroeder H; Beck Popovic M; Schreier G; Loibner H; Ambros P; Holmes K; Castellani MR; Gaze MN; Garaventa A; Pearson ADJ; Lode HN
Lancet Oncol; 2018 Dec; 19(12):1617-1629. PubMed ID: 30442501
[TBL] [Abstract][Full Text] [Related]
33. Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14).
Gillessen S; Plütschow A; Fuchs M; Markova J; Greil R; Topp MS; Meissner J; Zijlstra JM; Eichenauer DA; Bröckelmann PJ; Diehl V; Borchmann P; Engert A; von Tresckow B
Lancet Haematol; 2021 Apr; 8(4):e278-e288. PubMed ID: 33770483
[TBL] [Abstract][Full Text] [Related]
34. A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children's Oncology Group study†.
Chintagumpala M; Eckel SP; Krailo M; Morris M; Adesina A; Packer R; Lau C; Gajjar A
Neuro Oncol; 2015 Aug; 17(8):1132-8. PubMed ID: 25854526
[TBL] [Abstract][Full Text] [Related]
35. Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer Group.
Jennings MT; Sposto R; Boyett JM; Vezina LG; Holmes E; Berger MS; Bruggers CS; Bruner JM; Chan KW; Dusenbery KE; Ettinger LJ; Fitz CR; Lafond D; Mandelbaum DE; Massey V; McGuire W; McNeely L; Moulton T; Pollack IF; Shen V
J Clin Oncol; 2002 Aug; 20(16):3431-7. PubMed ID: 12177103
[TBL] [Abstract][Full Text] [Related]
36. A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade glioma.
Massimino M; Spreafico F; Riva D; Biassoni V; Poggi G; Solero C; Gandola L; Genitori L; Modena P; Simonetti F; Potepan P; Casanova M; Meazza C; Clerici CA; Catania S; Sardi I; Giangaspero F
J Neurooncol; 2010 Oct; 100(1):65-71. PubMed ID: 20151174
[TBL] [Abstract][Full Text] [Related]
37. Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancer.
Reck M; von Pawel J; Macha HN; Kaukel E; Deppermann KM; Bonnet R; Ulm K; Hessler S; Gatzemeier U
J Natl Cancer Inst; 2003 Aug; 95(15):1118-27. PubMed ID: 12902441
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma.
Bell EH; Zhang P; Shaw EG; Buckner JC; Barger GR; Bullard DE; Mehta MP; Gilbert MR; Brown PD; Stelzer KJ; McElroy JP; Fleming JL; Timmers CD; Becker AP; Salavaggione AL; Liu Z; Aldape K; Brachman DG; Gertler SZ; Murtha AD; Schultz CJ; Johnson D; Laack NN; Hunter GK; Crocker IR; Won M; Chakravarti A
J Clin Oncol; 2020 Oct; 38(29):3407-3417. PubMed ID: 32706640
[TBL] [Abstract][Full Text] [Related]
39. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
[TBL] [Abstract][Full Text] [Related]
40. Treatment of diencephalic syndrome with chemotherapy: growth, tumor response, and long term control.
Gropman AL; Packer RJ; Nicholson HS; Vezina LG; Jakacki R; Geyer R; Olson JM; Phillips P; Needle M; Broxson EH; Reaman G; Finlay J
Cancer; 1998 Jul; 83(1):166-72. PubMed ID: 9655307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
